Marex Group’s Neuronetics STIM Stock Holding History

Marex Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60,200	Closed	-$164K	–	1126
2025 Q3	$164K	Buy	+60,200	New	+$214K	﹤0.01%	742
2025 Q2	–	Sell	-24,000	Closed	-$88.3K	–	903
2025 Q1	$88.3K	Buy	+24,000	New	+$87.6K	﹤0.01%	623

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's STIM Position: Q4 2025 in Review

Marex Group sold out of Neuronetics (STIM) in Q4 2025, closing a stake of 60,200 shares — an estimated $164K sold.

Marex Group first reported a position in STIM in Q1 2025 and held it in 2 quarters. The position peaked at $164K in Q3 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

Marex Group reported no remaining Neuronetics position as of Q4 2025 after selling out during the quarter.
Marex Group sold 60,200 Neuronetics shares in Q4 2025, an estimated $164K.
Marex Group first reported a position in Neuronetics in Q1 2025 and held it in 2 quarters.
Marex Group's Neuronetics position peaked at $164K in Q3 2025.
95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.